SONOMA PHARMACEUTICALS, INC. (SNOA) Total liabilities 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) total liabilities at each fiscal year-end, per SEC filings.
$10.9MFY2026 · since FY2017: $4.0M → $10.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $10.9M | +17.1% |
| FY2025 | $9.3M | +7.9% |
| FY2024 | $8.6M | +4.2% |
| FY2023 | $8.3M | -18.7% |
| FY2022 | $10.1M | +5.4% |
| FY2021 | $9.6M | +7.7% |
| FY2020 | $8.9M | +125.7% |
| FY2019 | $4.0M | +2.0% |
| FY2018 | $3.9M | -3.7% |
| FY2017 | $4.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More SNOA financial trends
SNOA RevenueSNOA Net incomeSNOA Net marginSNOA Gross profitSNOA Gross marginSNOA Operating incomeSNOA Operating marginSNOA Operating cash flowSNOA Free cash flowSNOA Capital expendituresSNOA Return on equitySNOA Stock buybacksSNOA Dividends paidSNOA Total assetsSNOA Shareholders’ equitySNOA overview →